Day One Reports First Quarter 2024 Financial Results and Corporate Progress marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) .
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) CFO Charles N. York II sold 52,183 shares of the stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $17.89, for a total transaction of $933,553.87. Following the transaction, the chief financial officer now directly owns 225,571 shares […]
Day One Biopharmaceuticals, Inc (NASDAQ:DAWN) CEO Sells $163,398 90 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) CEO Jeremy Bender sold 70,051 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $17.88, for a total transaction of $1,252,511.88. Following the transaction, the chief executive officer now owns 651,762 shares of the […]